- Foreword
- Contributors
- 1 Primer on Depression
- 2 Neurobiology
- 3 Genetic Risk Factors of Depression
- 4 Environmental and Social Risk Factors in Depression
- 5 Biomarkers Predicting Antidepressant Treatment Response
- 6 Anxiety Disorders
- 7 Bipolar Disorder
- 8 Primer on Depression
- 9 General Medical Conditions
- 10 General Medical Conditions
- 11 First-Line and Combination Therapeutics for Major Depressive Disorder
- 12 Primer on Depression
- 13 Rapid-Acting Antidepressants
- 14 Management of Side Effects of Antidepressant Medications
- 15 Pharmacological Strategies for Targeting Residual Symptoms in Depression
- 16 Cognitive Behavior Therapy
- 17 Behavioral Activation for Depression
- 18 Psychodynamic and Supportive Psychotherapy
- 19 Neuromodulation for Depression
- 20 Exercise as a Treatment for Depression
- 21 Therapeutic Mindfulness and Depression
- 22 Probiotics and Nutraceuticals
- 23 Chronobiological Treatments
- 24 Child and Adolescent Depression
- 25 Depression in Older Adults
- 26 Postpartum Depression
- 27 Depression Following Mild Traumatic Brain Injury
- 28 Primer on Depression
- 29 Precision Medicine for the Treatment of Depression
- Index
(p. 399) Child and Adolescent Depression
- Chapter:
- (p. 399) Child and Adolescent Depression
- Author(s):
Andrew Diederich
, Jessica M. Jones
, and Graham J. Emslie
- DOI:
- 10.1093/med/9780190929565.003.0024
Early onset depression is prevalent and causes significant morbidity, mortality, and psychosocial impairment. Evidence-based psychosocial and psychopharmacological treatments are available for depressed youth, but many children and adolescents do not receive sufficient treatment. Pediatric and adult depressive disorders involve essentially the same symptoms, with the exception of irritability, as depressed youth may present with irritable mood in the absence of explicit sadness. This chapter examines aspects of depression that are unique to children and adolescents. It focuses on diagnosis and symptomatology, epidemiology, and pharmacological, psychotherapeutic, and other treatments. The chapter also addresses barriers to treatment of early onset depression and future research directions.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Foreword
- Contributors
- 1 Primer on Depression
- 2 Neurobiology
- 3 Genetic Risk Factors of Depression
- 4 Environmental and Social Risk Factors in Depression
- 5 Biomarkers Predicting Antidepressant Treatment Response
- 6 Anxiety Disorders
- 7 Bipolar Disorder
- 8 Primer on Depression
- 9 General Medical Conditions
- 10 General Medical Conditions
- 11 First-Line and Combination Therapeutics for Major Depressive Disorder
- 12 Primer on Depression
- 13 Rapid-Acting Antidepressants
- 14 Management of Side Effects of Antidepressant Medications
- 15 Pharmacological Strategies for Targeting Residual Symptoms in Depression
- 16 Cognitive Behavior Therapy
- 17 Behavioral Activation for Depression
- 18 Psychodynamic and Supportive Psychotherapy
- 19 Neuromodulation for Depression
- 20 Exercise as a Treatment for Depression
- 21 Therapeutic Mindfulness and Depression
- 22 Probiotics and Nutraceuticals
- 23 Chronobiological Treatments
- 24 Child and Adolescent Depression
- 25 Depression in Older Adults
- 26 Postpartum Depression
- 27 Depression Following Mild Traumatic Brain Injury
- 28 Primer on Depression
- 29 Precision Medicine for the Treatment of Depression
- Index